Random42, a London, UK-based technology-led digital agency serving the global pharmaceutical and biotech sectors, received an investment from Vespa Capital.The amount of the investment was not disclosed.
The company intends to use the funds to accelerate growth in current international markets, including North America and Japan.
Led by Ben Ramsbottom, Chief Executive Officer, Random42 provides the creative collateral for many international blockbuster drug launches, delivering animation and content across online, social and interactive campaigns.
FinSMEs
13/04/2015